news   news altcoin news bitcoin news breaking forex news brokers news business news commodities news cryptocurrency news elliott wave forecast forex industry news fracking news litecoin brokers medical marijuana stock market news bitcoin bitcoin affiliate programs bitcoin news widget buy bitcoins forex video tutorials shorting bitcoins trade bitcoins brokers forex brokers forex signals providers rebates forex demo account forex live accounts global regulators press releases binary options brokers binary options articles binary options school binary options signals affiliate programs education ask the experts books ebooks forex articles forex glossary trading courses webinars forex robots options forex tips fundamental reports market overview stock tips technical analysis reports technical outlook tools city times ticker exchange rates fibonacci calculator forexminute blog widget live forex rates ticker online currency converter pivot point calculator profit  loss calculator real time forex quotes trading signals more auto trading contribute forex charts trading software events webmaster tools rss search sign in welcome log into your account your username your password forgot your password get help create an account create an account welcome register for an account your email your username a password will be emailed to you password recovery recover your password your email a password will be emailed to you forexminute news altcoin news bitcoin news breaking forex news brokers news business news commodities news cryptocurrency news elliott wave forecast forex industry news fracking news litecoin brokers medical marijuana stock market news bitcoin bitcoin affiliate programs bitcoin news widget buy bitcoins forex video tutorials shorting bitcoins trade bitcoins brokers forex brokers forex signals providers rebates forex demo account forex live accounts global regulators press releases binary options brokers binary options articles binary options school binary options signals affiliate programs education ask the experts books ebooks forex articles forex glossary trading courses webinars forex robots options forex tips fundamental reports market overview stock tips technical analysis reports technical outlook tools city times ticker exchange rates fibonacci calculator forexminute blog widget live forex rates ticker online currency converter pivot point calculator profit  loss calculator real time forex quotes trading signals more auto trading contribute forex charts trading software events webmaster tools rss home news news latest latestfeatured postsmost popular days popularby review scorerandom destination maternity corp nasdaqdest is attracting smart money robert wright  july   pandolfino joseph picked nd century group inc nysemktxxii shares guess who picked alpine immune sciences inc nasdaqalpn shares novo holdings picked apollo endosurgery inc nasdaqapen shares eastern capital is buying cyclacel pharmaceuticals inc nasdaqcycc shares here is who picked hedgepath pharmaceuticals inc otcmktshppi shares robert wright  july    guess who picked kvh industries inc nysekvhi shares robert wright  july    saexploration holdings inc nasdaqsaex is attracting smart money robert wright  july    man group is buying sciclone pharmaceuticals inc nasdaqscln shares robert wright  july    here is who picked alpine immune sciences inc nasdaqalpn shares robert wright  july    here is who picked finjan holdings inc nasdaqfnjn shares robert wright  july    roy gulzar picked authentidate holding corp nasdaqadat shares robert wright  july    ali sohail is buying authentidate holding corp nasdaqadat robert wright  july    guess who picked future fintech group inc nasdaqftft shares robert wright  july    buffalo investor i picked semgroup corp nysesemg shares robert wright  july    hcsb financial corp otcmktshcfb is attracting smart money robert wright  july    here is who picked peabody energy corp nysebtu shares robert wright  july    page  of  broker of the month top online forex brokers reviewopen account reviewopen account top online binary brokers reviewopen account advice best investing advice risk warning all information on this website including any opinions charts prices news data buysell signals research and analysis is provided as general market commentary and does not constitute any investment advice forexminute is not liable for any damage or loss including but not limited to any loss of investment which may be based either directly orindirectly on the use of or reliance on such information before deciding whether or not to take part in foreign exchange or financial markets or any other type of financial instrument please carefully consider your investment objectives level of experience and risk appetite do not invest more money than you can afford to lose note that the high level of leverage in forex trading may work against you as well as for you please seek advice of an independent financial advisor if you are not fully aware about the risks associated with foreign exchange trading forex trading on margin involves considerable exposure to high risk and may not be suitable for all investors forexminute does not endorse any companies products or services which are represented on forexminutecom the information on this website is subject to change without notice about us contact us team terms  conditions privacy policy advertise  forexminute  featured brokers × flynn james e  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address  third avenue th floor new york ny   results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg pretpwinssretswins filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  rephrecro pharma incpahealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  rephrecro pharma incpahealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblesmi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblesi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblesmi  casmcas medical systems incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  casmcas medical systems incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  ivtyinvuity inccahealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  vndavanda pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  vndavanda pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  zfgnzafgen incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesi  boldaudentes therapeutics incdehealthbioprdbiological products no diagflynn james enythpossiblepdi  axgnaxogen incmnhealthelcmdelectromedical  electrotheraflynn james enythpossiblesi  axgnaxogen incmnhealthelcmdelectromedical  electrotheraflynn james enythpossiblesmi  syrssyros pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepdi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblesmi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblesi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblesmi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblesmi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblesmi  xnptxenoport incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  avxsavexis incdehealthbioprdbiological products no diagflynn james enydthpossiblepdmi  zfgnzafgen incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  xnptxenoport incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  zfgnzafgen incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  editeditas medicine incdehealthbioprdbiological products no diagflynn james enythpossiblepdi  xnptxenoport incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  vndavanda pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  vndavanda pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepami  strmstreamline health solutions incdetechsoftwcomputer integrated systems dflynn james enythpossiblesmi  vndavanda pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  alimalimera sciences incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  alimalimera sciences incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  alimalimera sciences incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  alimalimera sciences incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  alimalimera sciences incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  alimalimera sciences incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  alimalimera sciences incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ctmxcytomx therapeutics incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepdi  alimalimera sciences incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  atrsantares pharma incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  axgnaxogen incmnhealthelcmdelectromedical  electrotheraflynn james enythpossiblesi  rgnxregenxbio incdehealthbioprdbiological products no diagflynn james enythpossiblepdi  neosneos therapeutics incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepdi  neosneos therapeutics incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesdi  atrsantares pharma incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  atrsantares pharma incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  atrsantares pharma incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  atrsantares pharma incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesai  atrsantares pharma incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  nvlsnivalis therapeutics incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepdi  atrsantares pharma incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  atrsantares pharma incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  atrsantares pharma incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  lifeatyr pharma incdehealthbioprdbiological products no diagflynn james enythpossiblepdi  axgnaxogen incmnhealthelcmdelectromedical  electrotheraflynn james enythpossiblesi  stdysteadymed ltddehealthdrugpharmaceutical preparationsflynn james enythpossiblepdi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblepi  nvtainvitae corpdehealthhealthmedical laboratoriesflynn james enythpossiblepdi  aspxauspex pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblepi  casmcas medical systems incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblepi  casmcas medical systems incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesi  vndavanda pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  drnadicerna pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  drnadicerna pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesi  prtoproteon therapeutics incdehealthbioprdbiological products no diagflynn james enythpossiblepdi  drnadicerna pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblepi  loxoloxo oncology incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepdi  ehthehealth incdeinsurinsbrkinsurance agents brokers  sflynn james enythpossiblepmi  aavlavalanche biotechnologies incdehealthbioprdbiological products no diagflynn james enythpossiblepdi  trivtrivascular technologies incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblepdi  aspxauspex pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepdi  drnadicerna pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepdi  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesdi  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesi  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesami  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesdmi  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesmi  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesdi  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesi  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesmi  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesmi  tlontalon therapeutics incdehealthdrugpharmaceutical preparationsflynn james enydthpossiblesi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesmi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesami  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesmi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesmi  riglrigel pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesmi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesmi  tlontalon therapeutics inchealthdrugpharmaceutical preparationsflynn james enydthpossiblesmi  istaista pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  mdcomedicines co dedehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  mdcomedicines co dedehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  dusadusa pharmaceuticals incnjhealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  dusadusa pharmaceuticals incnjhealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  nuroneurometrix incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesi  hitkhi tech pharmacal co incnyhealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  nuroneurometrix incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  riglrigel pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesi  nuroneurometrix incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesi  nuroneurometrix incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  nuroneurometrix incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  nuroneurometrix incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesmi  mdcomedicines co dedehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  nuroneurometrix incdehealthmdeqsurgical  medical instrumentflynn james enythpossiblesi  fcscfibrocell science incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesi  mdcomedicines co dedehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  mdcomedicines co dedehealthdrugpharmaceutical preparationsflynn james enythpossiblesi  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsai  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsmi  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsmi  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsmi  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsi  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsi  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsmi  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsmi  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsmi  nuroneurometrix inchealthmdeqsurgical  medical instrumentflynn james enytpdi  slxpsalix pharmaceuticals ltdhealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  slxpsalix pharmaceuticals ltdhealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  prxpar pharmaceutical companies incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  slxpsalix pharmaceuticals ltdhealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  ngsxneurogesx inccahealthdrugpharmaceutical preparationsflynn james enythpossiblesi  ngsxneurogesx inccahealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  ngsxneurogesx inccahealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  ngsxneurogesx inccahealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  dusadusa pharmaceuticals incnjhealthdrugpharmaceutical preparationsflynn james enythpossiblepi  ngsxneurogesx inccahealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  nxtmnxstage medical incdehealthelcmdelectromedical  electrotheraflynn james enytsi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepnewi  dusadusa pharmaceuticals incnjhealthdrugpharmaceutical preparationsflynn james enythpossiblepi  emageemageon inctechsoftwprepackaged softwareflynn james enythpossiblesi  dusadusa pharmaceuticals incnjhealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  slxpsalix pharmaceuticals ltdhealthdrugpharmaceutical preparationsflynn james enythpossiblepi  slxpsalix pharmaceuticals ltdhealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesi  slxpsalix pharmaceuticals ltdhealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  slxpsalix pharmaceuticals ltdhealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  prxpar pharmaceutical companies incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesi  cycccyclacel pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  cycccyclacel pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enythpossiblesmi  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytsi  andsanadys pharmaceuticals inchealthdrugpharmaceutical preparationsflynn james enytsi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enythpossiblepmi  ntmdnitromed incdehealthdrugpharmaceutical preparationsflynn james enytpmi  viapvia pharmaceuticals incdehealthbioprdbiological products no diagflynn james enythpossiblesmi  viapvia pharmaceuticals incdehealthbioprdbiological products no diagflynn james enythpossiblesi  viapvia pharmaceuticals incdehealthbioprdbiological products no diagflynn james enythpossiblesi  viapvia pharmaceuticals incdehealthbioprdbiological products no diagflynn james enytsmi  arnaarena pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enytsi  viapvia pharmaceuticals incdehealthbioprdbiological products no diagflynn james enytsmi  twtithird wave technologies inc widehealthbioprdbiological products no diagflynn james enythpossiblesi  isphinspire pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enytsi  twtithird wave technologies inc widehealthbioprdbiological products no diagflynn james enythpossiblesmi  twtithird wave technologies inc widehealthbioprdbiological products no diagflynn james enythpossiblesmi  twtithird wave technologies inc widehealthbioprdbiological products no diagflynn james enythpossiblesmi  prxpar pharmaceutical companies incdehealthdrugpharmaceutical preparationsflynn james enytsmi  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytpi  prxpar pharmaceutical companies incdehealthdrugpharmaceutical preparationsflynn james enytpi  istaista pharmaceuticals incdehealthdiagnin vitro  in vivo diagnosticflynn james enytpi  istaista pharmaceuticals incdehealthdiagnin vitro  in vivo diagnosticflynn james enytpi  istaista pharmaceuticals incdehealthdiagnin vitro  in vivo diagnosticflynn james enytpmi  istaista pharmaceuticals incdehealthdiagnin vitro  in vivo diagnosticflynn james enytpmi  istaista pharmaceuticals incdehealthdiagnin vitro  in vivo diagnosticflynn james enytpmi  istaista pharmaceuticals incdehealthdiagnin vitro  in vivo diagnosticflynn james enytpi  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytpai  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytpmi  istaista pharmaceuticals incdehealthdiagnin vitro  in vivo diagnosticflynn james enytpmi  istaista pharmaceuticals incdehealthdiagnin vitro  in vivo diagnosticflynn james enytpmi  isphinspire pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enytpmi  isphinspire pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enytpi  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytpmi  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytpai  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytpmi  isphinspire pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enytpi  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytpmi  isphinspire pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enytpi  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytpmi  isphinspire pharmaceuticals incdehealthdrugpharmaceutical preparationsflynn james enytpi  dvaxdynavax technologies corpdehealthdrugpharmaceutical preparationsflynn james enytpmi dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft proteon therapeutics inc flynn james e bought stake trending stock news penny stock news stock news market news privacy policy proteon therapeutics inc flynn james e bought stake june    by henry gaston investors sentiment increased to  in q  its up  from  in q it increased as  investors sold proteon therapeutics inc shares while  reduced holdings  funds opened positions while  raised stakes  million shares or  less from  million shares in q were reported royal bancorporation of canada reported  of its portfolio in proteon therapeutics inc nasdaqprto geode management ltd liability co holds  or  shares in its portfolio vanguard group holds  shares or  of its portfolio manufacturers life ins the has invested  in proteon therapeutics inc nasdaqprto blackrock advsr llc accumulated  shares blackrock fund advsr invested  in proteon therapeutics inc nasdaqprto kcg has invested  in proteon therapeutics inc nasdaqprto finance counselors incorporated stated it has  in proteon therapeutics inc nasdaqprto deerfield mngmt company holds  of its portfolio in proteon therapeutics inc nasdaqprto for m shares mariner wealth advsr llc reported  of its portfolio in proteon therapeutics inc nasdaqprto bridgeway has  invested in proteon therapeutics inc nasdaqprto northern trust corporation holds  shares new yorkbased renaissance tech ltd liability has invested  in proteon therapeutics inc nasdaqprto mpm asset mngmt ltd llc invested in  shares or  of the stock deer vii and com holds  of its portfolio in proteon therapeutics inc nasdaqprto for  shares the new flynn james e holding in proteon therapeutics inc flynn james e reported sc d form with the sec for proteon therapeutics inc access it here  as reported by flynn james e the filler owns  or  shares of the company proteon therapeutics inc stake is new for reportingperson date of activity june  this shows flynn james e’s positive view for proteon therapeutics inc reasons why flynn james e bought – proteon therapeutics inc stock purpose of transaction the reporting personsacquired beneficial ownership of the securities reported herein for investment purposes on june   deerfieldprivate design fund iv lp “dpd iv” of which deerfield management is the investment manager the company and theother investors as defined in section  below entered into a securities purchase agreement the “purchase agreement”the terms of which are described in item  below the information set forth in item  below is incorporated into this item  byreference the reporting personsanticipate that jonathan leff a partner at deerfield management will be named to the board of directors of the company proteon therapeutics inc institutional sentiment filings show  investors own proteon therapeutics inc the ownership in q  is low at   of the outstanding shares this is increased by   were owned by these investors  funds opened new proteon therapeutics inc stakes  increased positions there were  that closed positions and  reduced them  investors had the stock in their top  some are deer vii  co ltd abingworth llp mpm asset management llc james e flynn deerfield management company is an investor bullish on proteon therapeutics inc owning  shares as of q  for  of its portfolio peter kolchinsky ra capital management llc owns  shares or  of its portfolio ny deer vii  company ltd have  of its portfolio for  shares further mpm asset management llc reported stake worth  of its portfolio the x abingworth llp owns  shares proteon therapeutics inc is  of its portfolio business profile proteon therapeutics inc is a latestage biopharmaceutical company which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease the company is involved in research and development activities the company’s product candidate product candidate vonapanitase formerly prt is a recombinant human elastase that it is developing to manage vascular access failure in patients with chronic kidney disease undergoing or planning for hemodialysis a lifesaving treatment that cannot be conducted without a functioning vascular access the company has completed phase ii trial of vonapanitase in patients undergoing creation of an arteriovenous fistula avf the company initiated the first of two phase iii trials patency for vonapanitase in radiocephalic avfs its vonapanitase product candidate is a recombinant human elastase under development as a treatment to prevent avf and arteriovenous graft avg patency loss sec form d it is down  since june   and is downtrending it has underperformed by  the sp proteon therapeutics inc is a latestage biopharmaceutical company which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease the company has market cap of  million the firm is involved in research and development activities it currently has negative earnings the company’s product candidate product candidate vonapanitase formerly prt is a recombinant human elastase that it is developing to manage vascular access failure in patients with chronic kidney disease undergoing or planning for hemodialysis a lifesaving treatment that cannot be conducted without a functioning vascular access proteon therapeutics inc nasdaqprto ratings coverage among  analysts covering proteon therapeutics nasdaqprto  have buy rating  sell and  hold therefore  are positive proteon therapeutics has  highest and  lowest target ’s average target is  above currents  stock price proteon therapeutics had  analyst reports since november   according to sratingsintel the firm has “strong buy” rating by raymond james given on wednesday october  on wednesday march  the stock rating was maintained by jmp securities with “market outperform” the firm has “neutral” rating by hc wainwright given on friday march  the firm has “neutral” rating by robert w baird given on tuesday december  the firm earned “hold” rating on wednesday december  by stifel nicolaus raymond james initiated the stock with “outperform” rating in wednesday november  report the firm earned “market perform” rating on wednesday december  by raymond james jmp securities downgraded proteon therapeutics inc nasdaqprto on wednesday december  to “market perform” rating maxim group initiated it with “buy” rating and  target in thursday november  report the stock of proteon therapeutics inc nasdaqprto has “market perform” rating given on wednesday december  by cowen  co more notable recent proteon therapeutics inc nasdaqprto news were published by bizjournalscom which released “novartis passes on m option to buy proteon therapeutics” on march   also seekingalphacom with their article “have you ever heard of proteon therapeutics” published on july   bizjournalscom published “proteon ceo new trial could be a path to market” on march   more interesting news about proteon therapeutics inc nasdaqprto were released by marketwatchcom and their article “” published on october   as well as quoteswsjcom‘s news article titled “news proteon therapeutics incprto” with publication date october   receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with our free daily email newsletter free email newsletter enter your email address below to get the latest news and analysts ratings for your stocks with our free daily email newsletter recent posts eps for third point reinsurance ltd tpre expected at  sound financial bancorp inc stock as institutional investors exit fidelity msci information tech etf ftec declines  for jul  what’s in heritagecrystal clean inc hcci after today’s huge increase could cesp cia energet otcmktscesjf change direction after more shorts ces energy solutions corporation otcmktscesdf on focus after report of more shorts today’s movers alexion pharmaceuticals nasdaqalxn stock rating maintained by bmo capital  target price indicates   potential cerulean pharma incorporated nasdaqceru can’t be more risky short interest increased blue sphere corp lazarus management co llc opened position  eps expected for teekay offshore partners lp too get the next big winner in your inbox before the bell listsconsumer eagle twitter auto publish powered by  xyzscriptscom james e flynn  deerfield management   stock picks and performance  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member home  hedge funds  deerfield management  profile hedge fund  deerfield management get email alerts profile holdings latest d  g filings news interviews and investor letters get email alerts profile holdings latest d  g filing news james e flynn bio returns net worth deerfield management managed by james e flynn since  is a healthcare focused investment company that specializes in funding rd managing hostile takeovers corporate transitions and financial advisory services deerfield management oversees  billion in assets fund profile filing period                            fund name deerfield management manager james e flynn portfolio value  change this qtr  top holdings login to see all holdings  sign up filing period                            last updated on may    pm based on sec f filings last update may    pm no security ticker shares value x activity  port  avexis inc     horizon pharma plc hznp      nxstage medical inc nxtm      horizon pharma invt ltdbond      gilead sciences inc gild    login to see all holdings  sign up its free news interviews and investor letters see all d filing james e flynn and alpine immune sciences inc alpn  comprised of shares held by deerfield special situations fund deerfield private design deerfield private design international deerfield private design ii and deerfield private design international read more july th   hedge funds  comments g filing james e flynn and marinus pharmaceuticals inc mrns  read more july th   hedge funds  comments g filing james e flynn and biocryst pharmaceuticals inc bcrx  read more june th   hedge funds  comments d filing james e flynn and avexis inc avxs  read more june st   hedge funds  comments g filing james e flynn and biocryst pharmaceuticals inc bcrx  read more may nd   hedge funds  comments d filing james e flynn and adeptus health inc adpt  read more may th   hedge funds  comments g filing james e flynn and ehealth inc ehth  read more may th   hedge funds  comments g filing james e flynn and proteon therapeutics inc prto  read more may rd   hedge funds  comments g filing james e flynn and audentes therapeutics inc bold  read more april th   hedge funds  comments d filing james e flynn and nivalis therapeutics inc nvls  read more april th   hedge funds  comments d filing james e flynn and adeptus health inc adpt  read more april th   hedge funds  comments g filing james e flynn and mannkind corp mnkd  read more april th   hedge funds  comments d filing james e flynn and adeptus health inc nyseadpt  read more april th   hedge funds  comments  biggest and most famous activist hedge funds after all activist hedge funds get most of their earnings from investing in companies and pushing them to provide more shareholder value these funds and their managers can start off with a statement read more february nd   hedge funds news  comments hedge fund news bill ackman deerfield management elliott management its official hedge fund titan bill ackman is moving pershing square capital to a new neighborhood his firm next year will take up residence in a west side building part of an area of manhattan that read more november nd   hedge funds  comments click here to see all news hedge fund resource center how to beat the market by  percentage points why track hedge funds download a free edition why you should dump your hedge funds  things you didnt know about hedge funds billionaire hedge funds warren buffett berkshire hathaway  david einhorn greenlight capital  george soros soros fund management  t boone pickens bp capital  jim simons renaissance technologies  leon cooperman omega advisors  carl icahn icahn capital lp  steve cohen point asset management  john paulson paulson  co  david tepper appaloosa management lp  home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft insider trading  flynn james e  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  flynn james e select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in goto page   next common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm invuity inc ivty flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view sale  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view sale  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view sale  pm zafgen inc zfgn flynn james edeerfield mgmt lpdeerfield partners lpdeerfield management codeerfield international master fund lpdeerfield special situations fund lpother owner    indirect view purchase  pm audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view sale  pm axogen inc axgn flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view sale  pm axogen inc axgn flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view purchase  am syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view purchase  pm xenoport inc xnpt flynn james edeerfield mgmt lpdeerfield management codeerfield partners lpdeerfield international master fund lpother owner    indirect view purchase  pm avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner    indirect view purchase  pm zafgen inc zfgn flynn james edeerfield mgmt lpdeerfield partners lpdeerfield management codeerfield international master fund lpdeerfield special situations fund lpother owner    indirect view purchase  pm xenoport inc xnpt flynn james edeerfield mgmt lpdeerfield management codeerfield partners lpdeerfield international master fund lpother owner    indirect view purchase  pm zafgen inc zfgn flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view purchase  pm editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner    indirect view purchase  pm xenoport inc xnpt flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view purchase  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view purchasea  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view sale  pm streamline health solutions inc strm flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view purchase  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view sale  pm antares pharma inc atrs flynn james edeerfield mgmt lpdeerfield management codeerfield partners lpdeerfield international master fund lpdeerfield special situations fund lpother owner    indirect view sale  pm axogen inc axgn flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view purchase  am regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner    indirect view purchase  am neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view sale  am neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view sale  pm antares pharma inc atrs flynn james edeerfield mgmt lpdeerfield management codeerfield partners lpdeerfield international master fund lpother owner    indirect view a indicate amendment filing stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm na nivalis therapeutics inc nvls flynn james edeerfield management codirector owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view purchase  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view purchase  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view option award  pm na avexis inc avxs flynn james edeerfield management codirectorother owner   indirect view option award  pm na avexis inc avxs flynn james edeerfield management codirectorother owner   indirect view conversion  pm nana editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner   indirect view conversion  pm nana editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner   indirect view conversion  pm nana editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner   indirect view conversion  pm nana editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner   indirect view conversion  pm nana cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner   indirect view conversion  am nana regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner   indirect view conversion  am nana regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner   indirect view conversion  am nana regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner   indirect view conversion  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view exercise  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view exercise  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view exercise  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view exercise  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view goto page   next   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  insider trading  flynn james e  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  flynn james e select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in goto page   next common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm invuity inc ivty flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view sale  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view sale  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view sale  pm zafgen inc zfgn flynn james edeerfield mgmt lpdeerfield partners lpdeerfield management codeerfield international master fund lpdeerfield special situations fund lpother owner    indirect view purchase  pm audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view sale  pm axogen inc axgn flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view sale  pm axogen inc axgn flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view purchase  am syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view sale  pm ehealth inc ehth flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view purchase  pm xenoport inc xnpt flynn james edeerfield mgmt lpdeerfield management codeerfield partners lpdeerfield international master fund lpother owner    indirect view purchase  pm avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner    indirect view purchase  pm zafgen inc zfgn flynn james edeerfield mgmt lpdeerfield partners lpdeerfield management codeerfield international master fund lpdeerfield special situations fund lpother owner    indirect view purchase  pm xenoport inc xnpt flynn james edeerfield mgmt lpdeerfield management codeerfield partners lpdeerfield international master fund lpother owner    indirect view purchase  pm zafgen inc zfgn flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpother owner    indirect view purchase  pm editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner    indirect view purchase  pm xenoport inc xnpt flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view purchase  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view purchasea  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view sale  pm streamline health solutions inc strm flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view purchase  pm vanda pharmaceuticals inc vnda flynn james edeerfield mgmt lpdeerfield management codeerfield international master fund lpdeerfield partners lpdeerfield special situations fund lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view purchase  pm cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view purchase  pm alimera sciences inc alim flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield private design fund ii lpdeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield private design international ii lpother owner    indirect view sale  pm antares pharma inc atrs flynn james edeerfield mgmt lpdeerfield management codeerfield partners lpdeerfield international master fund lpdeerfield special situations fund lpother owner    indirect view sale  pm axogen inc axgn flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpother owner    indirect view purchase  am regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner    indirect view purchase  am neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view sale  am neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner    indirect view sale  pm antares pharma inc atrs flynn james edeerfield mgmt lpdeerfield management codeerfield partners lpdeerfield international master fund lpother owner    indirect view a indicate amendment filing stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm na nivalis therapeutics inc nvls flynn james edeerfield management codirector owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana audentes therapeutics inc bold flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana syros pharmaceuticals inc syrs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view purchase  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view purchase  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view conversion  pm nana avexis inc avxs flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield partners lpdeerfield international master fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpdirectorother owner   indirect view option award  pm na avexis inc avxs flynn james edeerfield management codirectorother owner   indirect view option award  pm na avexis inc avxs flynn james edeerfield management codirectorother owner   indirect view conversion  pm nana editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner   indirect view conversion  pm nana editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner   indirect view conversion  pm nana editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner   indirect view conversion  pm nana editas medicine inc edit flynn james edeerfield mgmt iii lpdeerfield management codeerfield private design fund iii lpdeerfield healthcare innovations fund lpdeerfield mgmt hif lpother owner   indirect view conversion  pm nana cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  pm nana cytomx therapeutics inc ctmx flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner   indirect view conversion  am nana regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner   indirect view conversion  am nana regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner   indirect view conversion  am nana regenxbio inc rgnx flynn james edeerfield mgmt lpdeerfield management codeerfield mgmt iii lpdeerfield private design fund iii lpdeerfield international master fund lpdeerfield partners lpother owner   indirect view conversion  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view exercise  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view exercise  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view conversion  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view exercise  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view exercise  am nana neos therapeutics inc neos flynn james edeerfield mgmt lpdeerfield management codeerfield special situations fund lpdeerfield mgmt iii lpdeerfield private design fund iii lpother owner   indirect view goto page   next   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  flynn james e is buying avexis inc nasdaqavxs shares news altcoin news bitcoin news breaking forex news brokers news business news commodities news cryptocurrency news elliott wave forecast forex industry news fracking news litecoin brokers medical marijuana stock market news bitcoin bitcoin affiliate programs bitcoin news widget buy bitcoins forex video tutorials shorting bitcoins trade bitcoins brokers forex brokers forex signals providers rebates forex demo account forex live accounts global regulators press releases binary options brokers binary options articles binary options school binary options signals affiliate programs education ask the experts books ebooks forex articles forex glossary trading courses webinars forex robots options forex tips fundamental reports market overview stock tips technical analysis reports technical outlook tools city times ticker exchange rates fibonacci calculator forexminute blog widget live forex rates ticker online currency converter pivot point calculator profit  loss calculator real time forex quotes trading signals more auto trading contribute forex charts trading software events webmaster tools rss search sign in welcome log into your account your username your password forgot your password get help create an account create an account welcome register for an account your email your username a password will be emailed to you password recovery recover your password your email a password will be emailed to you forexminute news altcoin news bitcoin news breaking forex news brokers news business news commodities news cryptocurrency news elliott wave forecast forex industry news fracking news litecoin brokers medical marijuana stock market news bitcoin bitcoin affiliate programs bitcoin news widget buy bitcoins forex video tutorials shorting bitcoins trade bitcoins brokers forex brokers forex signals providers rebates forex demo account forex live accounts global regulators press releases binary options brokers binary options articles binary options school binary options signals affiliate programs education ask the experts books ebooks forex articles forex glossary trading courses webinars forex robots options forex tips fundamental reports market overview stock tips technical analysis reports technical outlook tools city times ticker exchange rates fibonacci calculator forexminute blog widget live forex rates ticker online currency converter pivot point calculator profit  loss calculator real time forex quotes trading signals more auto trading contribute forex charts trading software events webmaster tools rss home news flynn james e is buying avexis inc nasdaqavxs shares newsstock market news flynn james e is buying avexis inc nasdaqavxs shares by robert wright  may     share on facebook tweet on twitter in a just published form  filed with the us securities and exchange commission sec avexis inc nasdaqavxs reported that flynn james e has picked up  of common stock as of  the acquisition brings the aggregate amount owned by flynn james e to a total of  representing less than  stake in the company for those not familiar with the company avexis inc is a clinicalstage gene therapy company the company operates through the developing and commercializing gene therapy treatments for patients suffering from neurological genetic diseases segment the company’s product candidate avxs is its gene therapy product candidate that is in a phase i clinical trial for the treatment of spinal muscular atrophy sma type  which is a genetic disorder characterized by motor neuron loss and associated muscle deterioration the survival motor neuron smn is a protein for normal motor neuron signaling and function patients with sma type  either have experienced a deletion of their smn genes which prevents them from producing adequate levels of functional smn protein or carry a mutation in their smn gene avxs is designed to deliver a functional human smn gene into the nuclei of motor neurons that then generates an increase in smn protein levels a glance at avexis inc nasdaqavxs’s key stats reveals a current market capitalization of  billion based on  million shares outstanding and a price at last close of  per share looking at insider activity there are a few transactions worth noting specifically on  knudten picked up  at a purchase price of  this brings their total holding to  as of the date of the filing on the sell side the most recent transaction saw nagendran unload  shares at a sale price of  this brings their total holding to  it’s possible to gauge a company’s potential by tracking the activity of its major holders as well as checking in on insider activity such as those transactions listed above we’ll be keeping an eye on avexis inc nasdaqavxs as things move forward to see if its progress aligns with these transactions subscribe below and we’ll keep you on top of what’s happening before it moves markets       related articlesmore from author destination maternity corp nasdaqdest is attracting smart money pandolfino joseph picked nd century group inc nysemktxxii shares guess who picked alpine immune sciences inc nasdaqalpn shares broker of the month top online forex brokers reviewopen account reviewopen account top online binary brokers reviewopen account advice best investing advice risk warning all information on this website including any opinions charts prices news data buysell signals research and analysis is provided as general market commentary and does not constitute any investment advice forexminute is not liable for any damage or loss including but not limited to any loss of investment which may be based either directly orindirectly on the use of or reliance on such information before deciding whether or not to take part in foreign exchange or financial markets or any other type of financial instrument please carefully consider your investment objectives level of experience and risk appetite do not invest more money than you can afford to lose note that the high level of leverage in forex trading may work against you as well as for you please seek advice of an independent financial advisor if you are not fully aware about the risks associated with foreign exchange trading forex trading on margin involves considerable exposure to high risk and may not be suitable for all investors forexminute does not endorse any companies products or services which are represented on forexminutecom the information on this website is subject to change without notice about us contact us team terms  conditions privacy policy advertise  forexminute  featured brokers × flynn james e plumbing  heating  beltsville  hvac technicians in beltsville md let us find hvac professionals for you select a project additions and remodels appraisers and home inspectors architects asbestos basement waterproofing bathroom remodeling cabinets cabinets and countertops carpentry carpet carpet cleaning chimney sweeping cleaning concrete concrete and masonry cooling countertops custom homes decks and porches decorators and designers demolition doors drywall dumpster rental electrical engineers fences flooring foundations garage doors gutters handyman heating home appraisals home inspections home security hvac insulation junk removal kitchen remodeling landscaping locksmiths masonry mold mold asbestos and toxic materials painting pest control plumbing portable toilets pressure cleaning rental services roofing siding small projects and repairs solar energy sunrooms swimming pools tile work toxic materials tree service walls water damage restoration window cleaning windows log in sign up become a pro home  hvac  md  hvac beltsville   follow is this your business claim your business flynn james e plumbing  heating  ingelside dr  beltsville md  be the first to review this business beltsville md  phone  click to view the number hvac photos about the company flynn james e plumbing  heating in beltsville prince georges county  skilled contractors providing hvac products and services  ingelside dr beltsville is where anyone may get a hold of us recruiting ac renovators is expensive which means why squander much more than is needed flynn james e plumbing  heating concentrates on ac installations residential oil radiator installations engineering of domestic swamp coolers and redesigning of residential heat pumps we cover the beltsville maryland southern md facility college park and silver spring area beltsville southern md facility college park and silver spring are perfect places to be a homeowner its always flynn james e plumbing  heatings job to be certain that our clients have no need to be concerned about hvac issuesusing the best residential oil radiator installations professional for use on your job is vital to the eventual results of a project devoted to giving you fast excellent support to all of our customers we provide neighborhood hvac support every day the company is locally held and managed additional information bbb info bbb business review for flynn james e plumbing  heating time in business  years services offered hvac plumbing heating details are we a residential contractor yes are we a commercial contractor yes do we offer financing no do we have emergency service yes do we accept credit cards no find accurate prices for your hvac project in beltsville additional company information flynn james e plumbing  heating  hvac technicians in beltsville maryland in business since  better business bureau review and information on the company is available hours please call to confirm monday tuesday wednesday thursday friday saturday sunday am  pm am  pm am  pm am  pm am  pm closed closed reviews what is your rating of this business sign in with or pick a name submit id rather post as guest be the first to review this business request free quotes select a project additions and remodels appraisers and home inspectors architects asbestos basement waterproofing bathroom remodeling cabinets cabinets and countertops carpentry carpet carpet cleaning chimney sweeping cleaning concrete concrete and masonry cooling countertops custom homes decks and porches decorators and designers demolition doors drywall dumpster rental electrical engineers fences flooring foundations garage doors gutters handyman heating home appraisals home inspections home security hvac insulation junk removal kitchen remodeling landscaping locksmiths masonry mold mold asbestos and toxic materials painting pest control plumbing portable toilets pressure cleaning rental services roofing siding small projects and repairs solar energy sunrooms swimming pools tile work toxic materials tree service walls water damage restoration window cleaning windows type your zip code continue nearby contractors besche oil company rankin construction heating b  d plumbing  heating inc chesapeake systems inc aireflo heating  air conditioning inc suburban air conditioning about ehardhat ehardhat helps homeowners find great contractors for home improvement projects to get started browse the best beltsville hvac technicians read reviews find detailed contractor information on individual hvac technicians in beltsville and request free project estimates beltsville hvac pricesfinding accurate service costs before planning a remodeling project is important for keeping the overall project costs down are you looking to install hvac ductwork in beltsville soon find accurate beltsville hvac ductwork installation costs right nowknowing accurate remodeling costs upfront can help you negotiate more effectively with trade professionals and vendors and gauge whether their projects quotes are fair as compared to your local market costs to install hvac ductwork in beltsvillewe work hard to help you make confident decisions regarding which home products and services to purchase as well as help you identify trustworthy local beltsville hvac ductwork installation contractors our goal is to make sure you are able to have quality work completed at a fair price and on time other contractors in beltsville maryland handyman beltsville beltsville heating carpenters beltsville kitchen remodeling beltsville beltsville roofers painter beltsville landscapers beltsville home remodeling beltsville beltsville plumber electricians beltsville heating and air conditioning beltsville bathroom remodeling beltsville view other categories find maryland contractors hvac silver spring rockville hvac hvac glen burnie frederick hvac contractors hvac ellicott city columbia hvac hvac contractor baltimore waldorf hvac germantown hvac contractor hvac contractor dundalk follow us ehardhat on google ehardhat on facebook twitter ehardhat linkedin profile homeowners blog view top contractors sitemap  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z company home articles privacy policy terms our contractor app contractor directory careers faq affiliates contact us   ehardhat  all rights reserved member of the homeyou network help your friends find the best local contractors like our page no thanks i’m just looking deerfield  deerfield management  investmentteam home investment institute foundation news and events contact us investment our financing partners investment team investment team managing partner james e flynn biotechnology healthcare services medical devices pharmaceutical private transactions contacts james e flynn jim is the managing partner of deerfield he joined deerfield in  focusing on pharmaceutical companies and gradually assuming broader responsibility throughout the firm in  jim began comanaging the firm with deerfield’s founder arnold snider upon arnie’s retirement in  jim assumed his current role overseeing deerfield’s investment activities as well as the management of the firm since that time the firm has expanded its investment capabilities to include private structured financings developed additional proprietary market research instruments through the deerfield institute and created the deerfield foundation to contribute toward the health and welfare of disadvantaged children before joining deerfield jim was a top ranked analyst at furman selz from  to  where he built a team to cover the pharmaceutical and medical device industries and also managed a proprietary trading account previously he served from  to  as vice president of corporate development of alpharma inc a pharmaceutical company where his responsibilities included business development and strategic planning and the management of several licensing transactions jim began his career in healthcare investing from  to  at kidder peabody  co where he ultimately served as a senior analyst covering the specialty pharmaceutical industry since  jim has served as the chairman of the quality committee of the board of trustees of continuum health partners until its merger in  with mount sinai health system where he continues to serve on the board of trustees he also serves on the board of trustees of the new york academy of medicine he holds a bs in cellular and molecular biology and economics from the university of michigan   deerfield all rights reserved  contact  terms of use  privacy policy stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top vz log in for events urbn urbn syna ll hp log in for events alks cvrr cvrr esnd find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  proteon therapeutics inc flynn james e makes purchase trending business market stock privacy policy proteon therapeutics inc flynn james e makes purchase june    by louis casey investors sentiment increased to  in  q its up  from  in q it increased as  investors sold proteon therapeutics inc shares while  reduced holdings  funds opened positions while  raised stakes  million shares or  less from  million shares in q were reported  are held by geode capital mngmt californiabased pillar pacific mngmt ltd company has invested  in proteon therapeutics inc nasdaqprto royal commercial bank of canada accumulated  or  shares mariner wealth ltd owns  shares vanguard holds  of its portfolio in proteon therapeutics inc nasdaqprto for  shares perceptive advsr ltd liability company owns  shares fincl counselors stated it has  shares kornitzer ks holds  or  shares in its portfolio deer vii and communication limited reported  in proteon therapeutics inc nasdaqprto blackrock fund advsrs invested in  or  shares blackrock mgmt limited co invested  of its portfolio in proteon therapeutics inc nasdaqprto  are held by blackrock advisors ltd company moreover northern tru corporation has  invested in proteon therapeutics inc nasdaqprto  are held by bridgeway capital mgmt baker bros advsrs limited partnership has invested  in proteon therapeutics inc nasdaqprto the new flynn james e holding in proteon therapeutics inc flynn james e reported sc d form with the sec for proteon therapeutics inc access it here  as reported by flynn james e the filler owns  or  shares of the company proteon therapeutics inc stake is new for reportingperson date of activity june  this shows flynn james e’s positive view for proteon therapeutics inc reasons why flynn james e bought – proteon therapeutics inc stock purpose of transaction the reporting personsacquired beneficial ownership of the securities reported herein for investment purposes on june   deerfieldprivate design fund iv lp “dpd iv” of which deerfield management is the investment manager the company and theother investors as defined in section  below entered into a securities purchase agreement the “purchase agreement”the terms of which are described in item  below the information set forth in item  below is incorporated into this item  byreference the reporting personsanticipate that jonathan leff a partner at deerfield management will be named to the board of directors of the company proteon therapeutics inc institutional sentiment filings show  investors own proteon therapeutics inc the ownership in q  is low at   of the outstanding shares this is increased by   were owned by these investors  funds opened new proteon therapeutics inc stakes  increased positions there were  that closed positions and  reduced them  investors had the stock in their top  some are deer vii  co ltd abingworth llp mpm asset management llc james e flynn deerfield management company is an investor bullish on proteon therapeutics inc owning  shares as of q  for  of its portfolio peter kolchinsky ra capital management llc owns  shares or  of its portfolio ny deer vii  company ltd have  of its portfolio for  shares further mpm asset management llc reported stake worth  of its portfolio the x abingworth llp owns  shares proteon therapeutics inc is  of its portfolio business profile proteon therapeutics inc is a latestage biopharmaceutical company which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease the company is involved in research and development activities the company’s product candidate product candidate vonapanitase formerly prt is a recombinant human elastase that it is developing to manage vascular access failure in patients with chronic kidney disease undergoing or planning for hemodialysis a lifesaving treatment that cannot be conducted without a functioning vascular access the company has completed phase ii trial of vonapanitase in patients undergoing creation of an arteriovenous fistula avf the company initiated the first of two phase iii trials patency for vonapanitase in radiocephalic avfs its vonapanitase product candidate is a recombinant human elastase under development as a treatment to prevent avf and arteriovenous graft avg patency loss sec form d it is down  since june   and is downtrending it has underperformed by  the sp proteon therapeutics inc is a latestage biopharmaceutical company which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease the company has market cap of  million the firm is involved in research and development activities it currently has negative earnings the company’s product candidate product candidate vonapanitase formerly prt is a recombinant human elastase that it is developing to manage vascular access failure in patients with chronic kidney disease undergoing or planning for hemodialysis a lifesaving treatment that cannot be conducted without a functioning vascular access proteon therapeutics inc nasdaqprto ratings coverage among  analysts covering proteon therapeutics nasdaqprto  have buy rating  sell and  hold therefore  are positive proteon therapeutics has  highest and  lowest target ’s average target is  above currents  stock price proteon therapeutics had  analyst reports since november   according to sratingsintel the company was downgraded on wednesday december  by jmp securities the firm has “neutral” rating given on tuesday december  by robert w baird the stock has “buy” rating by maxim group on wednesday december  the firm has “outperform” rating by robert w baird given on thursday april  the stock has “market perform” rating by raymond james on wednesday december  the stock of proteon therapeutics inc nasdaqprto has “buy” rating given on thursday september  by hc wainwright the company was downgraded on wednesday december  by cowen  co the rating was upgraded by raymond james on wednesday october  to “strong buy” the firm has “neutral” rating given on friday march  by hc wainwright the stock of proteon therapeutics inc nasdaqprto earned “hold” rating by stifel nicolaus on wednesday december  more notable recent proteon therapeutics inc nasdaqprto news were published by globenewswirecom which released “proteon therapeutics appoints tony kingsley to its board of directors” on october   also marketwatchcom with their article “” published on october   bizjournalscom published “proteon ceo new trial could be a path to market” on march   more interesting news about proteon therapeutics inc nasdaqprto were released by bizjournalscom and their article “novartis passes on m option to buy proteon therapeutics” published on march   as well as seekingalphacom‘s news article titled “have you ever heard of proteon therapeutics” with publication date july   receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with our free daily email newsletter free email newsletter enter your email address below to get the latest news and analysts ratings for your stocks with our free daily email newsletter recent posts could cesp cia energet otcmktscesjf skyrocket the stock has too many sellers today bmo capital reaffirms a “outperform” rating on alexion pharmaceuticals nasdaqalxn and a  target price ces energy solutions corporation otcmktscesdf shorted shares increased  after market selling kelt exploration keltf can’t be more hot cerulean pharma incorporated nasdaqceru reports increase in sellers strong momentum for short players blue sphere corp lazarus management co llc bought stake eps for teekay offshore partners lp too expected at  is ezcorp inc ezpw a buy the stock rises again investors looking closely at canopy growth corporation ord twmjf slades ferry bancorp nasdaqsfbc institutional investors quarterly sentiment get the next big winner in your inbox before the bell listsconsumer eagle twitter auto publish powered by  xyzscriptscom search engine marketing sem  bing ads skip to content sign upsign in   you run your business well help find your customers bing ads can help build your business and drive your success spend  and get  in advertising credit† †offer details get  in search advertising when you spend  in bing ads coupon code class first name last name email your website url business phone required microsoft may contact you to provide updates and special offers about bing ads you can unsubscribe at any time to learn more you can read the privacy statement type the code from the image enter security code   × get  in search advertising when you spend  in bing ads †offer details offer expires december   valid only for new bing ads customers who are first party recipients of the offer email a new bing ads customer is one that has not advertised on bing ads before enter promotional coupon code and spend  applies to threshold and prepaid accounts to receive  in bing ads credits limit one promotion code per new bing ads customer promotional code must be redeemed within thirty  days of bing ads new customer account creation ad campaign costs accrued before receiving a credit as well as costs accrued after all credits are used will be charged to the payment method associated with the bing ads account if customer payment fails the coupon amount will not be applied ads will continue to run and accrue costs after any promotional credit has been used up any portion of the credit not used within ninety  days of credit redemption will expire and cant be carried over even if the bing ads customer switches their payment method offer valid only to residents of the united states in order for the offer to be valid a form of payment must be entered into your account prior to redemption of the promotional code and prior to your account going live to take advantage of the credit this offer may not be combined with any other offer promotional code coupon or discount separated redeemed for cash transferred sold or bartered microsoft in its sole discretion can close your account for any suspected coupon abuse refund of the  is not permitted see bing ads terms and conditions for more details at signup other terms and conditions may apply microsoft reserves the right to cancel change or suspend this offer at any time without notice see how bing ads works customers search customers see your ad customers contact you watch how bing ads works     × how bing ads works help more customers find you see how bing can attract customers your google adwords campaigns cant reach  million searchers on the bing network tap into  of the search marketplace get in front of searchers who spend  percent more than the average internet searcher powerful network powerful benefits reach across devicesconnect with customers looking for your business anytime anywhere on any device go global or localreach people in the bing network everywhere or focus on cities counties and areas within a certain distance from your business easy to importif youre already using another product like google adwords its easy to pull that campaign into bing ads you control your costs  free signupjoin bing ads for free and control your account at every step  only pay for clickspay just when customers click on your ad no click no charge  no minimum feestart advertising with a budget that works best for your business   the advantage we gain in cost per click gives us a great return on investment — more than  percent better than google adwords scott redgate search engine marketing manager — cj pony parts by using bing ads features like image extensions and sitelink extensions this auto parts retailer races to convert customers and beat its competition  read about driving more conversions   we might not get as much of the volume as with google adwords but the volume of the traffic that we get converts really well at a lower cost scott schult executive vice president of marketing — myrtle beach area convention and visitors bureau the myrtle beach area convention and visitors bureau uses bing ads to drive site traffic and tourism at lower cost  read about getting better roi better results for less cost thats as simple as i can make it if i look at the quality of the traffic we get for the dollars we spend on bing ads our roi is fantastic alex littlewood ceo   motoroso motoroso a market network for auto enthusiasts gets better results for less cost and reaches a highvalue audience with bing ads  read about attracting quality traffic   import your adwords campaigns save time by importing your google adwords campaigns into bing ads to get ads live quickly sign in with your microsoft account or create one to get started on bing ads from within the bing ads interface select the import from google adwords option enter your google adwords credentials and select the campaign you want to import preview your ad get found online with search engine marketing make the most of your marketing dollars and drive customers to your business see how bing ads can work for you get started today give us a few details about your business to create a bing ads account and get it up and running   sign up get started with bing ads signing up is always free faq is bing ads right for me is bing ads right for my business all types of businesses find value and success with bing ads whether youre focused on local calls and foot traffic or want to drive traffic to your website from across the country or around the world bing ads has solutions for you i already appear in search results for free why should i pay for advertising your current customers may search for your business by name aiming it easy to find you in search results but customers youve yet to reach are more likely searching for general terms that wouldnt necessarily bring up your business in search results advertising next to relevant bing search results puts your business front and center with interested customers you otherwise might not reach what is the difference between seo and sem which one is right for me search engine optimization seo is adjusting your website to improve your natural ranking in search results you cannot pay to improve your website ranking on bing or yahoo thus we often refer to these results and unpaid or organic search results clicks from seo are free but seo also requires technical expertise and involves some factors over which you have only limited control search engine marketing sem is paid advertising that appears next to or above unpaid or organic search results these paid ads are purchased through bing ads you pay for sem clicks but sem gives you more control over when your website appears on results pages and you decide how much you want to pay and you can measure which ads are working and quickly improve your results you dont have to choose between seo and sem you can do both if my time is limited should i still try bing ads yes call a bing ads specialist at and we’ll set up your first campaign for you for free we’ll give you tips on getting the most out of your ads and set you up for success we’re here to help about bing ads where does my ad appear your ads could appear on the top or to the right of bing yahoo and msn search results and you can choose to target your ads to different geographic regions times or days of the week and even demographics what determines my ad position bing ads is a payperclick ppc advertising system you bid based on how much you are willing to pay per each click on your ad because webpages have a limited number of places to show ads we auction those spaces you are bidding against other advertisers to get your ads into the space you want so if you bid on the keyword shoe you will have to beat the bids of the other advertisers who are also bidding on shoe you determine how much you are willing to bid your ad position is based on several things including how closely your ad and website fit with the terms that are searched relevance how your bid compares to other bids in the bing ads auction how strongly your ad has performed in the past and how often it has been clicked clickthrough rate the stronger you are in these areas the better your chances of winning the top ad position how to use bing ads how can i use bing ads to drive more people to my website here are some tips to get better results review your budget and bid strategy if your ad keeps pausing your budget limit may be set too low competitive bids help your ad stay in a strong position to catch eyes and get more clicks to your website expand your targeting both for location and for devices computer mobile and tablet make sure your ads and website are relevant to the keywords you bid on would someone searching your terms expect to see and ad for your business how can i keep my costs down while your first instinct may be to lower your budget first try lowering your maximum bids yes this could mean fewer customers visit your site but if you increase your quality score and build ads with a strong performance history you may be able to win a good ad position with a lower bid that would lower your costperclick and help stretch your budget how do i know if bing ads is working view a wide range of performance trends in your account to quickly see key stats ad clicks the number of times your ad appeared impressions spend average costperclick clickthrough rate average ad position cost per acquisition and conversions you can also run performance reports to get insights into how well your campaigns are doing can i run more than one ad yes in fact we encourage it only one ad will show at a time but running multiple ads lets you test different approaches to see whats working best with your target customers frequently businesses try out different ads for specific products or pages getting started with bing ads how do i get started sign up for bing ads which keywords should i choose you have a few options to help choose your keywords first youll want to think of the terms one of your customers might use to search for your products and offerings those search terms are a great starting point then you can use tools right in your account to find more keywords within bing ads click campaigns on the top of the page click the keywords tab and then click add keywords this will let you search for new keywords based on one you enter search a website for keywords search your destination urls for keywords how can i write a good ad here are a few tips that can help make your ad stand out keep your ads relevant one way to improve relevance is to use your customers most popular search terms in your ad titles and txt describe what sets your product apart use your customers language use words and writing tone that are likely to attract your typical customer be specific this clearer and more specific your offering the better for example rather than big discount specify and exact percentage such as  percent off give customers a reason to click your ad right now offer a specific call to action such as encouraging customers to request a brochure or consultation download a free ebook subscribe to a newsletter or take advantage of a limitedtime discount sign up with bing ads to get started flynn james e picked mannkind corp nasdaqmnkd shares  small cap exclusive flynn james e picked mannkind corp nasdaqmnkd shareshomebiotech healthcare newsflynn james e picked mannkind corp nasdaqmnkd shares flynn james e picked mannkind corp nasdaqmnkd shares april      richard schwarz  biotech  in a just published form  filed with the us securities and exchange commission sec mannkind corp nasdaqmnkd reported that flynn james e has picked up  of common stock as of the acquisition brings the aggregate amount owned by flynn james e to a total of  representing a  stake in the companyfor those not familiar with the company mannkind corporation is a biopharmaceutical company the company is focused on the discovery and development of therapeutic products for diseases such as diabetes its product candidate is afrezza which is an inhaled insulin used to control high blood sugar in adults with type i and type ii diabetes and helps in glycemic control afrezza consists of a dry formulation of human insulin delivered from a portable inhaler afrezza utilizes its technosphere formulation technology technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics technosphere powders are based on the company’s fumaryl diketopiperazine fdkp which is a potential of hydrogen phsensitive organic molecule that selfassembles into small particles under acidic conditions the company has also created a range of breathpowered dry powder inhalers its inhalers can be produced in both a reusable chronic treatment and a singleuse acute treatment formata glance at mannkind corp nasdaqmnkd’s key stats reveals a current market capitalization of  million based on  million shares outstanding and a price at last close of  per sharelooking at insider activity there are a few transactions worth notingspecifically on  pfeffer picked up  at a purchase price of  this brings their total holding to  as of the date of the filingon the sell side the most recent transaction saw alinaya unload  shares at a sale price of  this brings their total holding to it’s possible to gauge a company’s potential by tracking the activity of its major holders as well as checking in on insider activity such as those transactions listed above we’ll be keeping an eye on mannkind corp nasdaqmnkd as things move forward to see if its progress aligns with these transactionssubscribe below and we’ll keep you on top of what’s happening before it moves markets    tags biopharmaceuticals health care nasdaqmnkd share  richard schwarz richard schwarz is a veteran analyst in the small cap space with a particular focus on the development stage biotech sector he is a native of canada and attended nyu before working for a host of big name pharma outfitsrelated post guess who picked onconova therapeutics inc nasdaqontx shares may    arena pharmaceuticals inc nasdaqarna is attracting smart money april    here is who just picked ptc therapeutics inc nasdaqptct april    oncomed pharmaceuticals inc nasdaqomed is attracting smart money april    leave a reply cancel replyyour email address will not be published required fields are marked commentname  email  website top brokers review trade now reviewtrade now reviewtrade nowpromotioncopyright   all rights reservedtopenter your name and email and get the weekly newsletter its freeintroduce yourself and your programyour information will never be shared or sold to a rd party form sc g marinus pharmaceuticals filed by flynn james e research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form sc g marinus pharmaceuticals filed by flynn james e by k wizard—  pm et  httparchivefastedgarcomaqczykzhwxjjsmczd filed on july   more mrns news brieffda grants orphan drug designation for ganaxolone in cdkl disorder reuters   pm et  fda grants orphan drug designation for ganaxolone in cdkl disorder globenewswire   pm et  briefmarinus pharma initiated phase  clinical trial for ganaxolone iv reuters   am et  copyright – fmr llc  all rights reserved  terms of use privacy security site map